Cormorant Asset Management, LP Aclaris Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

  • $1.74 Billion
  • Q1 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$9.74 - $17.92 $8.77 Million - $16.1 Million
-900,000 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$12.27 - $18.49 $7.36 Million - $11.1 Million
-600,000 Reduced 40.0%
900,000 $13.1 Million
Q3 2021

Nov 15, 2021
SELL
$13.38 - $18.8 $6.69 Million - $9.4 Million
-500,000 Reduced 25.0%
1,500,000 $27 Million
Q1 2021

May 17, 2021
BUY
$5.86 - $27.73 $11.7 Million - $55.5 Million
2,000,000 New
2,000,000 $50.4 Million
Q4 2019

Feb 14, 2020
SELL
$1.02 - $1.97 $255,000 - $492,500
-250,000 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$2.13 - $7.06 $363,282 - $1.2 Million
-170,555 Reduced 40.55%
250,000 $548,000
Q1 2019

May 15, 2019
SELL
$5.63 - $7.84 $323,725 - $450,800
-57,500 Reduced 12.03%
420,555 $2.52 Million
Q4 2018

Feb 14, 2019
SELL
$6.3 - $15.4 $138,253 - $337,953
-21,945 Reduced 4.39%
478,055 $3.53 Million
Q3 2018

Nov 14, 2018
SELL
$14.38 - $20.89 $367,236 - $533,488
-25,538 Reduced 4.86%
500,000 $7.26 Million
Q1 2018

May 15, 2018
SELL
$17.08 - $25.64 $417,810 - $627,205
-24,462 Reduced 4.45%
525,538 $9.21 Million
Q3 2017

Nov 14, 2017
BUY
$23.02 - $28.8 $12.7 Million - $15.8 Million
550,000
550,000 $14.2 Million

Others Institutions Holding ACRS

# of Institutions
102
Shares Held
53.5M
Call Options Held
51K
Put Options Held
31.6K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $73.3M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email